# GPLB (Green Planet Bioengineering Co., Ltd.) - SEC EDGAR Financial Statements

> Green Planet Bioengineering Co., Ltd. reported $0 in total assets and a net loss of $42K through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/GPLB
- Markdown: https://convexityos.com/fundamentals/GPLB.md
- SEC CIK: 0001392449
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001392449&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -- | Operating profit |
| Net Income | FY 2025 | -$42K | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.00 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2019 | $0 | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Interest Expense | $0 | $0 | $300 | $0 | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$36K | -$36K | -$48K | -$33K | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$36K | -$36K | -$48K | -$33K | -$33K | -$34K | -$25K | -$40K | -$34K | -$36K |
| Basic EPS | -- | -- | -- | -- | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | -- | -- | -- | -- | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M |
| Diluted Shares Outstanding | 20.0M | 20.0M | 20.0M | -- | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Interest Expense | -- | -- | $150 | -- | -- | -- | -- | -- |
| Income Before Tax | -$8.4K | -$5.9K | -$11K | -$16K | -$8.6K | -$4.1K | -$6.8K | -$13K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$8.4K | -$5.9K | -$11K | -$16K | -$8.6K | -$4.1K | -$6.8K | -$13K |
| **Diluted EPS** | $0.00 | $0.00 | -- | -- | $0.00 | $0.00 | $0.00 | -- |
| Diluted Shares Outstanding | 20.0M | 20.0M | 20.0M | -- | 20.0M | 20.0M | 20.0M | -- |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Sep 2019 | Jun 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Cash & Short-Term Investments** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Current Assets** | -- | -- | $0 | -- | -- | -- | $0 | -- |
| **Total Non-Current Assets** | -- | -- | $0 | -- | -- | -- | $0 | -- |
| **Total Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Current Liabilities** | -- | -- | $258K | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | -- | -- | $0 | -- | -- | -- | -- | -- |
| **Total Liabilities** | $284K | $272K | $258K | $245K | $233K | $226K | $217K | $207K |
| Common Stock | $20K | $20K | $20K | $20K | $20K | $20K | $20K | $20K |
| Retained Earnings | -$913K | -$901K | -$887K | -$874K | -$863K | -$856K | -$847K | -$837K |
| **Total Stockholders' Equity** | -$284K | -$272K | -$258K | -$245K | -$233K | -$226K | -$217K | -$207K |
| Total Equity | -$284K | -$272K | -$258K | -$245K | -$233K | -$226K | -$217K | -$207K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$36K | -$36K | $48K | $33K | -$33K | -$34K | $64K | $8.4K | $12K | $12K |
| Change in Payables | -- | -- | -- | $0 | $0 | -$214 | $214 | $0 | $0 | $0 |
| **Operating Cash Flow** | -$37K | -$35K | -$43K | -$33K | -$33K | -$34K | -$37K | -$40K | $0 | $0 |
| **Investing Cash Flow** | -- | $35K | $43K | $0 | -- | -- | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $37K | $35K | $43K | $33K | $33K | $34K | $37K | $40K | $0 | $0 |
| **Net Change in Cash** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.4K | -$5.9K | -$11K | -$16K | -$8.6K | -$4.1K | -$6.8K | -$13K |
| **Operating Cash Flow** | -$8.4K | -$13K | -$17K | -$17K | -$6.6K | -$6.0K | -$6.9K | -$11K |
| **Investing Cash Flow** | -- | $0 | $0 | -- | $0 | $0 | $0 | $35K |
| **Financing Cash Flow** | $8.4K | $13K | $17K | $17K | $6.6K | $6.0K | $6.9K | $11K |
| **Net Change in Cash** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 10Y Net Income / Share Growth | -- | -- | -- | -- | -- | -104.2% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
